Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Study of TAS-114 in Healthy Adult Male Subjects
jRCT2080221521Phase 1
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Neoplasm comparing TAS-114 with Placebo (2 arms).
02
Drugs
TAS-114
03
Conditions
Neoplasm
Beyond the preview
Go deeper on jRCT2080221521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221521.